Loading...
Please wait, while we are loading the content...
Similar Documents
Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression
| Content Provider | Scilit |
|---|---|
| Author | Benoit, S. Toksoy, A. Brocker, E-B. Gillitzer, R. Goebeler, M. |
| Copyright Year | 2004 |
| Description | Journal: British Journal of Dermatology A 74-year-old Caucasian man with severe long-standing Palmoplantar pustular psoriasis (PPP) was treated with systemic therapy with efalizumab. Considerable improvement of PPP was observed after only 4 weeks of treatment and a complete recovery of daily activities was obtained after three months of therapy. A month later a sudden importantud ud absence of side effects; adult; aged; blood testis barrier; case report; drug withdrawal; human; labud reappearance of pustules wereud noted. Systemic acitretin at an initial dose of 0.5 mg/kg/dud was started while continuing efalizumab. After 15 days anud almost complete disappearance of pustular lesions was reobserved. The dermatosis relapsed after suspension of the retinoid, despite ongoing efalizumab |
| Ending Page | 1012 |
| Starting Page | 1009 |
| ISSN | 2573508X |
| e-ISSN | 13652133 |
| DOI | 10.1111/j.1365-2133.2004.05960.x |
| Journal | British Journal of Dermatology |
| Issue Number | 5 |
| Volume Number | 150 |
| Language | English |
| Publisher | Wiley-Blackwell |
| Publisher Date | 2004-05-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: British Journal of Dermatology Growth‐related Oncogene‐α Monocyte Chemoattractant Protein‐1 Pustular Psoriasis Tumour Necrosis Factor‐α |
| Content Type | Text |
| Resource Type | Article |